Rapid-Medical

Rapid Medical is an Israeli-based neurovascular medical device company specializing in innovative interventional tools for treating ischemic and hemorrhagic strokes. The company develops remotely adjustable, patient-anatomy-responsive devices that enable physicians to tailor endovascular procedures in real-time. With over 40,000 patients treated globally, 100+ issued patents, and 75+ clinical publications, Rapid Medical has established itself as a leader in neurovascular intervention. The company markets CE-marked devices including Pele, Comaneci, Bolt, TIGERTRIEVER 13, and DRIVEWIRE 24—all designed for mechanical thrombectomy, vessel remodeling, and aneurysm embolization. Recent clinical trials including the DISTALS trial demonstrate superior reperfusion outcomes in medium and distal vessel occlusions. With offices in Israel and the United States, Rapid Medical continues to expand its market presence in Europe and North America.